Tuberculosis (TB) is the most common opportunistic infection in Africa
n patients who die from AIDS, yet the stage of immunodeficiency at whi
ch TB develops is uncertain. We studied the immune status of HIV-infec
ted outpatients with pulmonary TB in relation to their clinical presen
tation in a cross-sectional study of 216 HIV-seropositive and 146 HIV-
seronegative ambulatory incident cases of smear-positive and culture-p
ositive pulmonary TB in Kinshasa, Zaire. HIV-seropositive and seronega
tive patients had median CD4 lymphocyte counts of 316.5/muL and 830.5/
muL, respectively. Of the HIV-seropositive patients, 32 9% had less th
an 200 CD4 lymphocytes/muL, 37% between 200 and 499, and 30.1% 500 or
more. Clinical AIDS, as defined by the WHO clinical case-definition or
a modified version, was of similar limited use as a predictor of immun
odeficiency. Among HIV-seropositive patients, oral candidosis, lymphop
enia, a negative tuberculin purified protein derivative test, and cuta
neous anergy were strongly associated with CD4 counts of less than 200
/muL, and seemed to be better markers of immune dysfunction. We conclu
de that pulmonary TB develops across a broad spectrum of HIV-induced i
mmunodeficiency and that a diagnosis of pulmonary TB is of limited use
as a marker of stage of HIV disease in African HIV-infected outpatien
ts.